You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/11130
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSteinwurz, Flavio-
dc.contributor.authorDenadai, Rafael-
dc.contributor.authorSaad-Hossne, Rogerio-
dc.contributor.authorQueiroz, Maria Luiza-
dc.contributor.authorTeixeira, Fabio Vieira-
dc.contributor.authorRomiti, Ricardo-
dc.date.accessioned2014-05-20T13:32:37Z-
dc.date.accessioned2016-10-25T16:50:55Z-
dc.date.available2014-05-20T13:32:37Z-
dc.date.available2016-10-25T16:50:55Z-
dc.date.issued2012-06-01-
dc.identifierhttp://dx.doi.org/10.1016/j.crohns.2011.12.007-
dc.identifier.citationJournal of Crohns & Colitis. Amsterdam: Elsevier B.V., v. 6, n. 5, p. 610-616, 2012.-
dc.identifier.issn1873-9946-
dc.identifier.urihttp://hdl.handle.net/11449/11130-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/11130-
dc.description.abstractAlthough therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon. (C) 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.en
dc.format.extent610-616-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectBiological therapyen
dc.subjectCrohn's diseaseen
dc.subjectInfliximaben
dc.subjectPsoriasisen
dc.subjectTumor necrosis factor-alpha inhibitorsen
dc.titleInfliximab-induced psoriasis during therapy for Crohn's diseaseen
dc.typeoutro-
dc.contributor.institutionHosp Israelita Albert Einstein-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationHosp Israelita Albert Einstein, Unit Inflammatory Bowel Dis, BR-05652900 São Paulo, Brazil-
dc.description.affiliationUniv State São Paulo UNESP, Botucatu Med Sch, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil-
dc.description.affiliationState Univ São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil-
dc.description.affiliationUniv State São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil-
dc.description.affiliationUniv São Paulo, Sch Med Sci, Dept Dermatol, São Paulo, Brazil-
dc.description.affiliationUnespUniv State São Paulo UNESP, Botucatu Med Sch, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil-
dc.description.affiliationUnespState Univ São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil-
dc.description.affiliationUnespUniv State São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil-
dc.identifier.doi10.1016/j.crohns.2011.12.007-
dc.identifier.wosWOS:000304689700016-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofJournal of Crohns & Colitis-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.